TopFunds

Centene Corporation

NYSE: CNC

Stock price

67.02 USD

(+0%) TODAY

Managed Health CareMedical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.4
1.7
2.4
2.3
3.1
3.1
2.3
2.1
5
6.3
(13.6)
-
02Free cash flow per share
2.1
4.7
3
1.4
1.8
8
5.6
9
13.3
(0.9)
8.8
15.6%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
$ 22,760
$ 40,607
$ 48,382
$ 60,116
$ 74,639
$ 111,115
$ 125,982
$ 144,547
$ 153,999
$ 163,071
$ 194,777
24%
06% Change
-
78.4%
19.2%
24.3%
24.2%
48.9%
13.4%
14.7%
6.5%
5.9%
19.4%
24%
07Cost of revenue
(20,014)
(35,063)
(42,581)
(51,695)
(65,796)
(95,899)
(111,783)
(127,891)
(136,684)
(146,242)
(170,944)
23.9%
08Gross profit
2,746
5,544
5,801
8,421
8,843
15,216
14,199
16,656
17,315
16,829
23,833
24.1%
09% Margin
12.1%
13.7%
12%
14%
11.9%
13.7%
11.3%
11.5%
11.2%
10.3%
12.2%
12.2% A
10Operating expenses
(2,041)
(4,281)
(4,602)
(6,963)
(7,062)
(12,134)
(12,415)
(15,338)
(14,385)
(13,654)
(31,452)
31.5%
11% of Revenue
(9)%
(10.5)%
(9.5)%
(11.6)%
(9.5)%
(10.9)%
(9.9)%
(10.6)%
(9.3)%
(8.4)%
(16.2)%
(10.5)% A
12Operating Income
705
1,263
1,199
1,458
1,781
3,082
1,784
1,318
2,930
3,175
(7,618)
-
13Income tax expense
(339)
(599)
(326)
(474)
(473)
(979)
(477)
(760)
(899)
(963)
(51)
-
14Net Income
355
562
828
900
1,321
1,808
1,347
1,202
2,702
3,305
(6,673)
-
15% Margin
1.6%
1.4%
1.7%
1.5%
1.8%
1.6%
1.1%
0.8%
1.8%
2%
(3.4)%
1.1% A
16Shares Outstanding
246,133
327,951
353,092
398,506
420,409
579,135
590,516
582,040
545,704
523,744
491,071
7.2%
17EPS Basic
1.5
1.8
2.4
2.3
3.2
3.2
2.3
2.1
5
6.3
(13.6)
-
18EPS Diluted
1.4
1.7
2.4
2.3
3.1
3.1
2.3
2.1
5
6.3
(13.6)
-
19EBITDA
851
1,655
1,750
2,206
2,837
4,760
3,954
4,180
5,616
6,200
(5,140)
-
% Margin
3.7%
4.1%
3.6%
3.7%
3.8%
4.3%
3.1%
2.9%
3.7%
3.8%
(2.6)%
3.1% A
20Net Interest Income (expense)
(43)
(217)
(255)
(343)
(412)
(728)
(665)
(665)
(725)
(702)
(678)
31.8%
21Net Debt / EBITDA
(0.6)
0.4
0.4
0.6
0.8
1.6
2.4
2.2
0.3
0.9
(0.2)
0.8 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,760
3,930
4,072
5,342
12,123
10,800
13,118
12,074
17,193
14,063
17,888
26.1%
23Short-term investments
176
505
531
722
863
1,580
1,539
2,321
2,459
2,622
-
-
24Accounts receivable
1,279
3,215
3,413
5,150
6,247
9,696
12,238
13,272
15,532
19,713
18,105
30.3%
25Other current assets
390
715
687
784
1,090
1,317
1,602
2,461
5,572
1,601
-
-
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
3,605
8,365
8,703
11,998
20,323
23,393
28,497
30,128
40,756
37,999
35,993
25.9%
Non-Current Assets
28Net property, plant & equipment
518
797
1,104
1,706
2,782
2,774
6,957
4,986
2,415
2,426
2,354
16.3%
29Long-term investments
1,927
4,545
5,312
6,861
7,717
12,853
14,043
14,684
16,286
17,429
20,879
26.9%
30Other non-current assets
1,289
6,490
6,736
10,336
10,172
29,699
28,878
27,072
25,184
24,591
18,435
30.5%
31Total Non-Current Assets
3,734
11,832
13,152
18,903
20,671
45,326
49,878
46,742
43,885
44,446
41,668
27.3%
Total Assets
7,339
20,197
21,855
30,901
40,994
68,719
78,375
76,870
84,641
82,445
77,661
26.6%
LIABILITIES
Current Liabilities
32Accounts payable
976
3,763
4,165
4,051
4,003
7,069
8,289
9,345
16,252
13,016
20,544
35.6%
33Short-term debt
5
4
4
38
249
301
471
262
287
268
196
44.3%
34Other current liabilities
2,648
4,856
5,163
7,882
8,680
14,215
17,005
18,857
20,177
20,977
736
(12)%
35Total Current Liabilities
3,629
8,623
9,332
11,971
12,932
21,585
25,765
28,464
36,716
34,261
21,476
19.5%
Non-Current Liabilities
36Long-term debt
1,216
4,651
4,695
6,648
14,260
18,016
22,190
21,071
18,590
19,161
18,581
31.4%
37Other non-current liabilities
170
869
952
1,259
1,110
3,156
3,398
3,098
3,379
2,513
17,548
59%
38Total Non-Current Liabilities
1,386
5,520
5,647
7,907
15,370
21,172
25,588
24,169
21,969
21,674
36,129
38.6%
39Total Liabilities
5,015
14,143
14,979
19,878
28,302
42,757
51,353
52,633
58,685
55,935
57,605
27.7%
SHAREHOLDERS` EQUITY
40Common stock
-
-
4,349
-
-
1
1
1
1
1
1
-
41Retained earnings / (deficit)
1,358
1,920
2,748
3,663
4,984
6,792
8,139
9,341
12,043
15,348
8,674
20.4%
42Accumulated other comprehensive income / (loss)
(10)
(36)
(3)
(56)
134
337
77
(1,132)
(652)
(504)
(58)
19.2%
43Noncontrolling interests
167
159
26
106
141
189
227
180
116
100
103
(4.7)%
44Total shareholders' equity
2,324
6,054
6,876
11,023
12,692
25,962
27,022
24,237
25,956
26,510
20,056
24.1%
45Total Liabilities and shareholders' Equity
7,339
20,197
21,855
30,901
40,994
68,719
78,375
76,870
84,641
82,445
77,661
26.6%
46Total Debt
1,221
4,655
4,699
6,686
14,509
18,317
22,661
21,333
18,877
19,429
18,777
31.4%
47Net Debt
(539)
725
627
1,344
2,386
7,517
9,543
9,259
1,684
5,366
889
-
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
355
562
828
900
1,321
1,808
1,347
1,202
2,702
3,305
(6,673)
-
49Depreciation & amortization
111
278
361
495
643
1,259
1,476
1,553
1,293
1,241
1,275
27.7%
50Share-based compensation expense
71
148
135
145
177
281
203
234
216
212
204
11.1%
51Changes in working capital and other assets
121
863
165
(306)
(658)
2,155
1,179
3,272
3,842
(4,604)
10,282
55.9%
52Net cash flows from operating activities
658
1,851
1,489
1,234
1,483
5,503
4,205
6,261
8,053
154
5,088
22.7%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(150)
(306)
(422)
(675)
(730)
(869)
(910)
(1,004)
(799)
(644)
(767)
17.7%
54Purchases of investments / marketable securities
(1,321)
(2,450)
(2,704)
(3,846)
(2,575)
(7,402)
(7,400)
(6,736)
(6,622)
(7,183)
(4,541)
13.1%
55Proceeds from maturities of marketable securities
669
1,656
1,899
1,991
1,809
4,921
5,458
3,802
5,523
5,785
5,780
24.1%
56Other investing activities
(11)
(1,297)
(38)
(2,055)
(36)
(3,605)
(447)
1,017
619
990
(19)
5.6%
57Net cash flows from investing activities
(813)
(2,397)
(1,265)
(4,585)
(1,532)
(6,955)
(3,299)
(2,921)
(1,279)
(1,052)
453
-
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(40)
(63)
(65)
2,708
(75)
(626)
(297)
(3,026)
(1,589)
(3,078)
(438)
27%
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
338
2,794
44
1,969
6,870
920
1,761
(1,130)
19
678
(1,145)
-
61Other financing activities
(4)
(14)
5
9
16
(34)
(102)
(41)
-
(6)
(19)
16.9%
62Net cash flows from financing activities
294
2,717
(16)
4,686
6,811
260
1,362
(4,197)
(1,570)
(2,406)
(1,602)
-
63Increase (decrease) in cash and cash equivalents
150
2,170
142
1,270
6,781
(1,323)
2,318
(1,044)
5,119
(3,130)
3,825
38.3%
64Cash and equivalents, ending balance
1,760
3,930
4,072
5,342
12,123
10,800
13,118
12,074
17,193
14,063
17,957
26.2%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
508
1,545
1,067
559
753
4,634
3,295
5,257
7,254
(490)
4,321
23.9%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Centene Corporation (CNC) financial statements and performance

Explore Centene Corporation (CNC) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.